Plain-English translation of NCT06249672 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Rectal cancer is often treated with radiation and chemotherapy before surgery. When the cancer shrinks significantly or disappears, some patients may avoid major surgery altogether and instead use an organ-preservation strategy. This trial is comparing two approaches: one where you're monitored closely without additional surgery, and another where doctors perform a small procedure to remove the remaining scar tissue after your initial radiation and chemotherapy treatment.
Major rectal cancer surgery can cause long-term problems with bowel, bladder, and sexual function. This trial exists to understand whether keeping your rectum through careful monitoring—with or without a minor surgical procedure—works as well as traditional surgery while avoiding these serious side effects.
You likely qualify if…
You likely don't qualify if…
You will be placed into one of two groups: either careful monitoring with imaging and endoscopy exams, or the same monitoring plus a minimally invasive surgical procedure to remove the scar tissue where your tumor was. Both groups will have long-term follow-up visits to track how well your rectum functions and to make sure the cancer does not return. The study will track your quality of life, bowel and urinary function, and other health outcomes over time.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Switzerland